Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease

Introduction. The metabolic syndrome (MS) affects 21–53% of patients with chronic obstructive pulmonary disease (COPD) with a higher prevalence in the early stages of COPD, with results being highly variable between studies. MS may also affect natural course of COPD—number of exacerbations, quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekov, Evgeni, Slavova, Yanina, Tsakova, Adelina, Genova, Marianka, Kostadinov, Dimitar, Minchev, Delcho, Marinova, Dora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2015
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493698/
https://www.ncbi.nlm.nih.gov/pubmed/26157632
http://dx.doi.org/10.7717/peerj.1068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493698/
https://www.ncbi.nlm.nih.gov/pubmed/26157632
http://dx.doi.org/10.7717/peerj.1068

Ejemplares similares